Allied BioScience (ABS), a Dallas-based biotechnology company specializing in antimicrobial coatings for public spaces, announced that it is among Lydia Partners’ initial round of multimillion-dollar investments in consumer technology, healthcare, and biomedical ventures.

The capital will be used to scale operations and meet a surging demand, it said. The amount was undisclosed.

Investor Lydia Partners is a newly formed venture capital firm with offices in Plano, Frisco, and Pensacola, Fla.

With the deal, Lydia Partner Managing Director, Mohammad “Rab” Shanableh, has been appointed to the board of directors for Allied BioScience. He joins the Board just as demand surges for disruptive infection prevention for public spaces, the company said in a release.

In the “current global pandemic, investment in paradigm-shifting technologies that support public health is critical,” Shanableh said.

Surface protection for public health

Founded in 2005, Allied BioScience is on a mission to deliver eco-friendly, research-driven products and services. The biotechnology company specializes in antimicrobial coatings designed to reduce infection and illness across public spaces, a need the COVID-19 crisis has highlighted. 

ABS calls its patented coatings “Always On” surface protection. Providing 90 days of continuous surface protection, they have been proven to drive significant reductions in both bioburdens and correlated Healthcare-Associated Infections, the company stated.

Its antimicrobial surface protection, SurfaceWise, provides an invisible barrier to inviting the growth of bacteria, fungi (mold and mildew), and algae. Odorless and invisible, the coating bonds to the surface and creates a hostile environment that prevents organisms from attaching and thriving on the treated surface. 

Shanableh brings 25 years of tech experience to ABS, with previously held executive positions in operations, development, and systems engineering while leading divisions that pioneered the way of Mobile Packet Network. He was also the co-founder and VP of Global Operations at Affirmed Networks, which was named to Forbes’ Global Unicorn Club, an award recognizing outstanding current private companies valued at more than $1B.

That’s a boon to ABS, according to Mike Ruley, Allied BioScience’s Chief Executive Officer. “Given his success delivering inflection point growth at early-stage and large companies, we look forward to Rab’s expertise in bringing our revolutionary continuous antimicrobial coatings to broad application during this critical time.”

Shanableh said: “With the solutions that Allied BioScience brings to market to help mitigate transmission of pathogens, and the strength of their leadership and experience in infection control, we look forward to scaling operations and pursuing channels for which their products can meet public health need.”

Quincy Preston contributed to this report.

Get on the list.
Dallas Innovates, every day.

Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.